Neuroscientific Biopharmaceuticals Ltd (NSB) - Total Liabilities

Latest as of December 2025: AU$207.87K AUD ≈ $147.08K USD

Based on the latest financial reports, Neuroscientific Biopharmaceuticals Ltd (NSB) has total liabilities worth AU$207.87K AUD (≈ $147.08K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Neuroscientific Biopharmaceuticals Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Neuroscientific Biopharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. See NSB net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Neuroscientific Biopharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Neuroscientific Biopharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Ancora Indonesia Resources Tbk JK:OKAS	Indonesia	Rp92.74 Million
Magnum Ventures Limited NSE:MAGNUM	India	Rs5.24 Billion
Principal Technologies Inc V:PTEC	Canada	CA$1.32 Million
EV Nickel Inc V:EVNI	Canada	CA$190.62K
Vertex Resource Group Ltd V:VTX	Canada	CA$149.53 Million
Orege Société Anonyme PA:OREGE	France	€60.58 Million
17 Education Technology Group Inc NASDAQ:YQ	USA	$148.36 Million
Klassik Radio AG XETRA:KA8	Germany	€5.90 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Neuroscientific Biopharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Neuroscientific Biopharmaceuticals Ltd (NSB) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	31.62	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	5.33	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.01	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.01	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neuroscientific Biopharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neuroscientific Biopharmaceuticals Ltd (2016–2025)

The table below shows the annual total liabilities of Neuroscientific Biopharmaceuticals Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$149.22K ≈ $105.59K	+74.16%
2024-06-30	AU$85.68K ≈ $60.63K	-85.66%
2023-06-30	AU$597.36K ≈ $422.67K	-73.06%
2022-06-30	AU$2.22 Million ≈ $1.57 Million	+892.65%
2021-06-30	AU$223.41K ≈ $158.08K	+152.35%
2020-06-30	AU$88.53K ≈ $62.64K	+41.70%
2019-06-30	AU$62.48K ≈ $44.21K	-18.21%
2018-06-30	AU$76.39K ≈ $54.05K	+77.02%
2017-06-30	AU$43.15K ≈ $30.53K	-64.66%
2016-06-30	AU$122.12K ≈ $86.41K	--

About Neuroscientific Biopharmaceuticals Ltd

AU:NSB Australia Biotechnology

Market Cap

$14.59 Million

AU$20.62 Million AUD

Market Cap Rank

#26082 Global

#1182 in Australia

Share Price

AU$0.06

Change (1 day)

-6.06%

52-Week Range

AU$0.06 - AU$0.25

All Time High

AU$0.52